Ro Khanna bought AbbVie Inc (NYSE: ABBV)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 57 trades in AbbVie Inc (ABBV) since 2017, 34 purchases and 23 sales, worth an estimated $677K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Ro Khanna bought $15,001 - $50,000 of AbbVie Inc (NYSE: ABBV) on February 19, 2025. Since that trade, ABBV is up +39.04% against the S&P 500 up +20.74%, an outperformance of +18.30%.
Across these filings, Ro Khanna has been a net buyer of ABBV (a buy-to-sell ratio of 1.48). The most recent disclosed ABBV transaction shown was dated June 2, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Ro Khanna's ABBV trades vs the price
ABBV is up +39.04% since Ro Khanna bought on February 19, 2025, versus +20.74% for the S&P 500.
Performance since this trade
All Ro Khanna ABBV trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Ro Khanna & ABBV trading FAQ
Is it legal for Ro Khanna to trade AbbVie Inc (ABBV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna buy ABBV?
Ro Khanna disclosed a purchase of $15,001 - $50,000 of AbbVie Inc (ABBV) on February 19, 2025, according to public STOCK Act filings.
How has ABBV performed since Ro Khanna's trade?
Since Ro Khanna bought ABBV on February 19, 2025, the stock is up +39.04%, versus +20.74% for the S&P 500 over the same period, an outperformance of +18.30%.
How many times has Ro Khanna traded ABBV?
Ro Khanna has disclosed 57 ABBV trades since 2017 (34 purchases and 23 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABBV trades?
Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's ABBV tradesAll congressional filings for AbbVie IncRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.